On 31st of January, a bland-new Mohn Research Centre for Regenerative Medicine was officially launched.

The centre was funded by the Trond Mohn Foundation in collaboration with the University of Bergen and Haukeland University Hospital in Bergen.

In the centre, there will be a number of preclinical and clinical studies planned, which include:

• Stem cell transplantation for wound healing
• Stem cells for treating osteonecrosis
• Personalised medicine in psychosis treatment
• Establishing “blue print” protocols for gene therapy

Furthermore, a new ex vivo facility for GMP-graded stem cell production has been established, which facilities cell-based therapies in the region.

Our group will be involved in mesenchymal stem cell (MSC) production for preclinical and clinical studies, development of MSC-based therapy for osteonecrosis and a number of collaborative work among research groups in the centre.

You can find more information here in detail.